SS

Subramanyam Singiri

Active Director Designated Partner DIN 09725943
DIN 09725943 First appointment Jan 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Subramanyam Singiri

Data last updated:

Subramanyam Singiri is a Designated Partner at Avigna Laboratories Tirupati Llp (since 2022). The company operates in Healthcare.

DIN 09725943
Primary Designation Designated Partner
Industry Healthcare
First Appointment 21 Jan 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Jan 20222022Active

Board colleagues of Subramanyam Singiri

Directorship timeline

Open interactive timeline →
Avigna Laboratories Tirupati Llp
Premium access

Shareholding and investment profile for Subramanyam Singiri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subramanyam Singiri

Subramanyam Singiri currently holds 1 directorship: Avigna Laboratories Tirupati Llp (Designated Partner, since 21 Jan 2022).

Subramanyam Singiri was first appointed on 21 Jan 2022 as Designated Partner at Avigna Laboratories Tirupati Llp.

The current boards of Subramanyam Singiri's companies include Arief Basha Shaik (Avigna Laboratories Tirupati Llp), Kishore Animireddy (Avigna Laboratories Tirupati Llp), Siva Prasada Rao Jampani (Avigna Laboratories Tirupati Llp), Vadlamudi Tharanath (Avigna Laboratories Tirupati Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available